Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay.
about
Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2.Roscovitine in cancer and other diseasesHER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancerDifferential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancerEpigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas.HER2 and breast cancer stem cells: more than meets the eye.Targeted therapy in breast cancer: the HER-2/neu gene and protein.Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells?Increased Level of Phosphorylated ShcA Measured by Chemiluminescence-Linked Immunoassay Is a Predictor of Good Prognosis in Primary Breast Cancer Expressing Low Levels of Estrogen Receptor.The silent estrogen receptor--can we make it speak?Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance.Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors.NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer.
P2860
Q24810517-27B76735-E8E8-4016-A42F-B841FB67F7B2Q26799874-1DE7F9C6-7CFB-466D-8126-AC0BB2C9728CQ28085413-23756AE0-1E32-43AA-BBFC-BE3624BEFF4FQ33533628-FCF27410-E334-4AA3-B81E-4A01328D390BQ34365668-7836F38B-7C1D-454D-8310-2EC7C0255251Q35320325-D2A48BDA-88E9-4DDB-9F3E-08555D90DFACQ35648508-A465A5BB-AAD1-4E77-A22F-D27190A9FF80Q36438357-FB1EE3B2-7527-4AB4-AB59-A3FC0732101DQ37307192-96642528-3477-4DB4-A643-72880497E3AFQ37468213-0B489F6C-5C92-4EE9-855D-81E2D9E89E18Q40718678-F54ACCD5-5CA4-4964-A7F8-E2C4C8DBAF62Q44157521-A176E319-A445-4D4C-A5C7-7E8FB785DD9AQ46866288-2EB12E92-5C75-475D-B1B7-F6EA4CF8CC7D
P2860
Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prognostic and predictive sign ...... easured by enzyme immunoassay.
@ast
Prognostic and predictive sign ...... easured by enzyme immunoassay.
@en
type
label
Prognostic and predictive sign ...... easured by enzyme immunoassay.
@ast
Prognostic and predictive sign ...... easured by enzyme immunoassay.
@en
prefLabel
Prognostic and predictive sign ...... easured by enzyme immunoassay.
@ast
Prognostic and predictive sign ...... easured by enzyme immunoassay.
@en
P2093
P1476
Prognostic and predictive sign ...... easured by enzyme immunoassay.
@en
P2093
F Bannwart
F Schoumacher
H Dieterich
S Eppenberger-Castori
P304
P356
10.1200/JCO.2001.19.3.645
P407
P577
2001-02-01T00:00:00Z